Health Care/Hospital
Gannex's Strategic Partner Sagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASH
Denifanstat achieved statistically significant results on primary and multiple secondary endpoints in a 52-week clinical trial of 168 NASH patients with stage 2 or 3 fibrosis - Primary efficacy endpoints: * NASH resolution without worsening of fibrosis with ≥2-point reduction in NAS (NAFLD A...
2024-01-23 12:17
1352
First Myeloma Patient Treated with CAR-T Successfully Discharged
SHANGHAI, Jan. 23, 2024 /PRNewswire/ -- In another milestone since the implementation of CAR-T therapy at Jiahui, the first myeloma patient treated with CAR-T at Jiahui International Hospital was recently discharged two weeks after infusion. The foreign patient was first diagnosed with multiple ...
2024-01-23 10:19
1773
Extensive R&D Capabilities：ICP DAS - BMP to Showcase a Broad Range of Medical-Grade TPU at MD&M West 2024, U.S.
HSINCHU, Jan. 23, 2024 /PRNewswire/ -- ICP DAS – BMP, Asia's first medical-grade thermoplastic polyurethane (TPU) supplier, will make its MD&M West debut inthe United States. Kicking off 2024, the company presents a comprehensive range of top-quality medical-grade TPU series to the foremost expe...
2024-01-23 10:06
1944
YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024
GAITHERSBURG, Md., Jan. 23, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma") along with its subsidiaries ("YS Group" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and ...
2024-01-23 06:00
2442
Telix Highlights Presentations at Upcoming ASCO Genitourinary Cancers Symposium (ASCO GU 2024)
MELBOURNE, Australia, Jan. 22, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces presentations featuring the Company's theranostic programs at the upcoming American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU 2024) to be he...
2024-01-22 19:00
1328
Asia Research News provides a source-finding platform for journalists
A one-stop resource for expertise and science is now available. Get tip sheets for research stories fromAsia. CAMBRIDGE, England and PENANG, Malaysia, Jan. 22, 2024 /PRNewswire/ -- Asia Research News, the unrivalled leader of scientific news and experts forAsia, is set to sail into its 20th yea...
2024-01-22 17:00
1618
KL Wellness City Drives Healthcare Tourism with IoT Integration
KUALA LUMPUR, Malaysia, Jan. 22, 2024 /PRNewswire/ -- Since its grand launch in June 2023, KL Wellness City (KLWC) has been a trailblazer, reshaping integrated healthcare and wellness. This visionary city, housing the flagship KL International Hospital (KLIH) and The Nobel Healthcare Park, is set...
2024-01-22 12:50
1792
Guangdong on the Road | Angels that give sight in Fiji
GUANGZHOU, China, Jan. 22, 2024 /PRNewswire/ -- Through the "Guangdong on the Road" series, GDToday joins hands with global reporters and sheds light on Guangdong's partnership under the Belt and Road Initiative. 2023 marks the 60th anniversary of China dispatching its first Chinese medical te...
2024-01-22 10:35
1626
xTool's First-Ever Brand Safety Campaign Kicks Off with a Notable Trade-In Program
IRWINDALE, Calif., Jan. 22, 2024 /PRNewswire/ -- xTool
2024-01-22 10:00
1328
Everest Medicines Announces 2023 Revenue Expected to be Between RMB124 Million and RMB126 Million
SHANGHAI, Jan. 22, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, announced today that the Company expects to record a total reven...
2024-01-22 07:50
3104
/C O R R E C T I O N -- Life Fitness/
In the news release, EGYM and Life Fitness Expands Existing Global Partnership, issued18-Jan-2024 by Life Fitness over PR Newswire, we are advised by the company that the second paragraph, second sentence, should read "..is expected to be launched in the first half of 2024" rather than "..is expe...
2024-01-19 23:42
4191
Top Employer 2024 certification reflects Boehringer Ingelheim Vietnam's impactful people development
HO CHI MINH CITY, Vietnam, Jan. 19, 2024 /PRNewswire/ -- For the fifth consecutive year, Boehringer Ingelheim Vietnam, a biopharmaceutical company focused on research, has received recognition for its exceptionalworkplace. Globally, Boehringer Ingelheim has been recognized as a "Global Top Employ...
2024-01-19 19:28
1577
Call for Application for 2024 Tsinghua Amgen Scholars Program
BEIJING, Jan. 19, 2024 /PRNewswire/ -- The Amgen Scholars Program (ASP) is an international program funded by the Amgen Foundation with the direction of Harvard University, aiming to increase research opportunities for students committed to pursuing careers in the field of biomedical science. Thr...
2024-01-19 15:32
2524
Top Employer 2024 certification reflects Boehringer Ingelheim's impactful people development in Indonesia
Note: This press release, with MLR code: MPR-ID-100139, supersedes the version issued on 18/01/2024, 11:00. * Boehringer Ingelheim recognized as one of 17 Top Employers worldwide and for the sixth consecutive year inIndonesia * High scores in development and steering (strategy and leadershi...
2024-01-19 13:15
1417
Co-creating a New Future: Infinitus Global Annual Conference 2024 Convenes in Guangdong
GUANGZHOU, China, Jan. 18, 2024 /PRNewswire/ -- Infinitus kicked off 2024 with
the 'Co-creating a New Future' annual conference held in Foshan,Guangdong on
January 13, 2024.
2024-01-19 11:42
1748
Airai Global Corporation Officially Team Up with Airai State Government Palau Joint Developed Integrated Luxuries Tourism & Modern Wellness Transformation Program
Double Collaboration Agreement Signing Marks a Milestone at Sheraton Petaling Jaya Hotel KUALA LUMPUR, Malaysia, Jan. 19, 2024 /PRNewswire/ -- The Airai State Government welcomes Airai Global Corporation in a historic collaboration to revolutionize eco-tourism and healthcare inPalau. This transf...
2024-01-19 10:00
1771
Leapstack has raised nearly 200 million RMB in Series C+ Funding, building a diversified technological value chain for health insurance
SHANGHAI, Jan. 18, 2024 /PRNewswire/ -- Leapstack, a prominent insurtech company, recently secured an impressive200 million RMB yuan in Series C+ Funding, led by Qiming Venture Partners. The funding round also saw active participation from Soochow Yihe Capital, and existing shareholder Legend Ca...
2024-01-18 22:34
1797
Leapstack has raised nearly 200 million RMB in Series C+ Funding, building a diversified technological value chain for health insurance
SHANGHAI, Jan. 18, 2024 /PRNewswire/ -- Leapstack, a prominent insurtech company, recently secured an impressive200 million RMB yuan in Series C+ Funding, led by Qiming Venture Partners. The funding round also saw active participation from Soochow Yihe Capital, and existing shareholder Legend Ca...
2024-01-18 22:18
1821
PeproMene Bio, Inc. Announces Complete Remission of the Cohort 1 First Patient Treated for Relapsed and Refractory B-cell Acute Lymphoblastic Leukemia (B-ALL) in the Phase 1 Clinical Trial of PMB-CT01 (BAFFR-CAR T Cells) at City of Hope
IRVINE, Calif., Jan. 18, 2024 /PRNewswire/ -- PeproMene Bio, Inc., a clinical-stage biotech company developing novel therapies to treat cancers and immune disorders, today announced that the cohort 1 first patient treated in its Phase 1 relapsed or refractory B-cell acute lymphoblastic leukemia (...
2024-01-18 16:00
2215
Top Employer 2024 certification reflects Boehringer Ingelheim's impactful people development in Asia Pacific
* Boehringer Ingelheim is recognized as one of 17 Top Employers worldwide and for the fifth consecutive year inAsia Pacific * High scores in development and steering (strategy and leadership) practices highlight Boehringer Ingelheim's continued commitment to employee wellbeing and development...
2024-01-18 12:00
1492
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Multiple achievements made in China-Hungary BRI conference
[Picked up by 310 media titles]
2024-05-03 06:59
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 293 media titles]
2024-04-30 10:11
Xinhua president, Hungarian economy minister vow to bolster media cooperation
[Picked up by 282 media titles]
2024-05-03 06:25TAILG Makes Grand Appearance at 2024 Asiabike Jakarta, Aiming to Set the Benchmark in Indonesia
[Picked up by 257 media titles]
2024-05-02 01:21
Most Read
/C O R R E C T I O N -- Addverb/
2024-05-03 20:26
7371
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
2024-04-30 10:11
6145
Multiple achievements made in China-Hungary BRI conference
2024-05-03 06:59
5052
Xinhua president, Hungarian economy minister vow to bolster media cooperation
2024-05-03 06:25
4707
